SYM 2259
Alternative Names: SYM-2259Latest Information Update: 06 Nov 2006
At a glance
- Originator Annovis
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy; Neurological disorders
Most Recent Events
- 06 Nov 2006 Discontinued - Preclinical for Epilepsy in USA (unspecified route)
- 06 Nov 2006 Discontinued - Preclinical for Neurological disorders in USA (unspecified route)
- 04 Dec 2003 No development reported - Preclinical for Epilepsy in USA (unspecified route)